Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation
Authors
Keywords
-
Journal
ANGIOGENESIS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-30
DOI
10.1007/s10456-020-09722-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Paraxial Mesoderm Is the Major Source of Lymphatic Endothelium
- (2019) Oliver A. Stone et al. DEVELOPMENTAL CELL
- Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner
- (2019) Ralitsa R. Madsen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A xenograft model for venous malformation
- (2018) Jillian Goines et al. ANGIOGENESIS
- Phosphatidylinositol 3-Kinase α–Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study
- (2018) Dejan Juric et al. JOURNAL OF CLINICAL ONCOLOGY
- In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)
- (2018) C. Ranieri et al. NEUROGENETICS
- Etiology and Genetics of Congenital Vascular Lesions
- (2018) Angela Queisser et al. OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA
- Vascular Anomalies
- (2018) Arin K. Greene et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations
- (2018) Hannah Blesinger et al. PLoS One
- PI3K/mTOR inhibition promotes the regression of experimental vascular malformations driven by PIK3CA-activating mutations
- (2018) Laura di Blasio et al. Cell Death & Disease
- Combined capillary-venous-lymphatic malformations without overgrowth in patients with Klippel-Trénaunay syndrome
- (2018) Elisa Brandigi et al. Journal of Vascular Surgery-Venous and Lymphatic Disorders
- Targeted therapy in patients with PIK3CA-related overgrowth syndrome
- (2018) Quitterie Venot et al. NATURE
- Cancer-Associated PIK3CA Mutations in Overgrowth Disorders
- (2018) Ralitsa R. Madsen et al. TRENDS IN MOLECULAR MEDICINE
- Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly
- (2018) Lara Rodriguez-Laguna et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study
- (2018) Jennifer Hammer et al. Orphanet Journal of Rare Diseases
- Molecular diagnosis of PIK3CA-related overgrowth spectrum (PROS) in 162 patients and recommendations for genetic testing
- (2017) Paul Kuentz et al. GENETICS IN MEDICINE
- Somatic GNAQ Mutation is Enriched in Brain Endothelial Cells in Sturge–Weber Syndrome
- (2017) Lan Huang et al. PEDIATRIC NEUROLOGY
- CLOVES syndrome: review of a PIK3CA-related overgrowth spectrum (PROS)
- (2016) A. Martinez-Lopez et al. CLINICAL GENETICS
- Discovery of 3-(3-(4-(1-Aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine (ARQ 092): An Orally Bioavailable, Selective, and Potent Allosteric AKT Inhibitor
- (2016) Jean-Marc Lapierre et al. JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
- (2016) D. M. Adams et al. PEDIATRICS
- Endothelial Cells from Capillary Malformations Are Enriched for Somatic GNAQ Mutations
- (2016) Javier A. Couto et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- Somatic PIK3CA mutations as a driver of sporadic venous malformations
- (2016) Pau Castel et al. Science Translational Medicine
- PI3K inhibitors as new cancer therapeutics: implications for clinical trial design
- (2016) Cristian Massacesi et al. OncoTargets and Therapy
- Somatic Activating PIK3CA Mutations Cause Venous Malformation
- (2015) Nisha Limaye et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Nonvenous Origin of Dermal Lymphatic Vasculature
- (2015) I. Martinez-Corral et al. CIRCULATION RESEARCH
- Heterozygous expression of the oncogenic Pik3caH1047R mutation during murine development results in fatal embryonic and extraembryonic defects
- (2015) Lauren M. Hare et al. DEVELOPMENTAL BIOLOGY
- Lymphatic and Other Vascular Malformative/Overgrowth Disorders Are Caused by Somatic Mutations in PIK3CA
- (2015) Valerie L. Luks et al. JOURNAL OF PEDIATRICS
- Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
- (2015) M. Wassef et al. PEDIATRICS
- PIK3CA-related overgrowth spectrum (PROS): Diagnostic and testing eligibility criteria, differential diagnosis, and evaluation
- (2014) Kim M. Keppler-Noreuil et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Clinical delineation and natural history of thePIK3CA-related overgrowth spectrum
- (2014) Kim M. Keppler-Noreuil et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation
- (2014) Elisa Boscolo et al. ANGIOGENESIS
- Activating PIK3CA alleles and lymphangiogenic phenotype of lymphatic endothelial cells isolated from lymphatic malformations
- (2014) Alexander J. Osborn et al. HUMAN MOLECULAR GENETICS
- Regulation of angiogenesis by PI3K signaling networks
- (2013) Mariona Graupera et al. EXPERIMENTAL CELL RESEARCH
- Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin
- (2013) Wa Du et al. LABORATORY INVESTIGATION
- Sturge–Weber Syndrome and Port-Wine Stains Caused by Somatic Mutation in GNAQ
- (2013) Matthew D. Shirley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES Syndrome
- (2012) Kyle C. Kurek et al. AMERICAN JOURNAL OF HUMAN GENETICS
- De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
- (2012) Jean-Baptiste Rivière et al. NATURE GENETICS
- Sirolimus for the treatment of complicated vascular anomalies in children
- (2011) Adrienne M. Hammill et al. PEDIATRIC BLOOD & CANCER
- Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome
- (2008) Ahmad I. Alomari CLINICAL DYSMORPHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started